AAAAAA

   
Results: 1-12 |
Results: 12

Authors: GIJSMAN HJ VANGERVEN JMA TIELEMAN MC SCHOEMAKER RC PIETERS MSM FERRARI MD COHEN AF VANKEMPEN GMJ
Citation: Hj. Gijsman et al., PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE OF ORAL AND INTRAVENOUS META-CHLOROPHENYLPIPERAZINE IN HEALTHY-VOLUNTEERS, Journal of clinical psychopharmacology, 18(4), 1998, pp. 289-295

Authors: VANHAARST AD VANTKLOOSTER GAE VANGERVEN JMA SCHOEMAKER RC VANOENE JC BURGGRAAF J COENE MC COHEN AF
Citation: Ad. Vanhaarst et al., THE INFLUENCE OF CISAPRIDE AND CLARITHROMYCIN ON QT INTERVALS IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 542-546

Authors: DEROODE A VANGERVEN JMA COHEN AF SCHOEMAKER RC BOVILL JG
Citation: A. Deroode et al., THE EFFECTS OF 2 LEVELS OF MIDAZOLAM (M) AND PROPOFOL (P), USING TARGET-CONTROLLED INFUSION (TCI), ON MEMORY AND SEDATION, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 57-57

Authors: DINGEMANSE J VANGERVEN JMA SCHOEMAKER RC RONCARI G OBERYE JJL VANOOSTENBRUGGEN MF MASSARELLA J SEGALA P ZELL M COHEN AF
Citation: J. Dingemanse et al., INTEGRATED PHARMACOKINETICS AND PHARMACODYNAMICS OF RO-48-6791, A NEWBENZODIAZEPINE, IN COMPARISON WITH MIDAZOLAM DURING FIRST ADMINISTRATION TO HEALTHY MALE-SUBJECTS, British journal of clinical pharmacology, 44(5), 1997, pp. 477-486

Authors: VANGERVEN JMA RONCARI G SCHOEMAKER RC MASSARELLA J KEESMAAT P KOOYMAN H HEIZMANN P ZELL M COHEN AF DINGEMANSE J
Citation: Jma. Vangerven et al., INTEGRATED PHARMACOKINETICS AND PHARMACODYNAMICS OF RO-48-8684, A NEWBENZODIAZEPINE, IN COMPARISON WITH MIDAZOLAM DURING FIRST ADMINISTRATION TO HEALTHY MALE-SUBJECTS, British journal of clinical pharmacology, 44(5), 1997, pp. 487-493

Authors: VANSTEVENINCK AL WALLNOFER AE SCHOEMAKER RC PIETERS MSM DANHOF M VANGERVEN JMA COHEN AF
Citation: Al. Vansteveninck et al., A STUDY OF THE EFFECTS OF LONG-TERM USE ON INDIVIDUAL SENSITIVITY TO TEMAZEPAM AND LORAZEPAM IN A CLINICAL POPULATION, British journal of clinical pharmacology, 44(3), 1997, pp. 267-275

Authors: VANGERVEN JMA SCHOEMAKER RC JACOBS LD REINTS A OUWERSLOOTVANDERMEIJ MJ HOEDEMAKER HGJ COHEN AF
Citation: Jma. Vangerven et al., SELF-MEDICATION OF A SINGLE HEADACHE EPISODE WITH KETOPROFEN, IBUPROFEN OR PLACEBO, HOME-MONITORED WITH AN ELECTRONIC PATIENT DIARY, British journal of clinical pharmacology, 42(4), 1996, pp. 475-481

Authors: VANGERVEN JMA TJONATSIEN AML
Citation: Jma. Vangerven et Aml. Tjonatsien, THE EFFICACY OF ALDOSE REDUCTASE INHIBITORS IN THE MANAGEMENT OF DIABETIC COMPLICATIONS - COMPARISON WITH INTENSIVE INSULIN-TREATMENT AND PANCREATIC TRANSPLANTATION, Drugs & aging, 6(1), 1995, pp. 9-28

Authors: VANGERVEN JMA MOLL JWB VANDENBENT MJ BONTENBAL M VANDERBURG MEL VERWEIJ J VECHT CJ
Citation: Jma. Vangerven et al., PACLITAXEL (TAXOL) INDUCES CUMULATIVE MILD NEUROTOXICITY, European journal of cancer, 30A(8), 1994, pp. 1074-1077

Authors: VANGERVEN JMA HOVESTADT A MOLL JWB RODENBURG CJ SPLINTER TAW VANOOSTEROM AT KEIZER L DROGENDIJK TE GROENHOUT CM VECHT CJ NEIJT JP
Citation: Jma. Vangerven et al., THE EFFECTS OF AN ACTH-[4-9] ANALOG ON DEVELOPMENT OF CISPLATIN NEUROPATHY IN TESTICULAR CANCER - A RANDOMIZED TRIAL, Journal of neurology, 241(7), 1994, pp. 432-435

Authors: VANGERVEN JMA BOOT JP LEMKES HHPJ VANBEST JA
Citation: Jma. Vangerven et al., EFFECTS OF ALDOSE REDUCTASE INHIBITION WITH TOLRESTAT ON DIABETIC-RETINOPATHY IN A 6 MONTHS DOUBLE-BLIND TRIAL, Documenta ophthalmologica, 87(4), 1994, pp. 355-365

Authors: VANGERVEN JMA
Citation: Jma. Vangerven, FURTHER CLINICAL-STUDIES WITH AN ALDOSE REDUCTASE INHIBITOR IN DIABETIC NEUROPATHY, Diabetic medicine, 10(5), 1993, pp. 35-38
Risultati: 1-12 |